会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • AN ULTRASOUND EQUIPMENT FOR TREATING OF EDEMA AND USE THEREOF
    • 一种超声波处理设备及其应用
    • WO2009017264A1
    • 2009-02-05
    • PCT/KR2007/003653
    • 2007-07-30
    • REGENPRIME CO., LTD.MIN, Byoung-HyunPARK, So RaKWON, Soon Keun
    • MIN, Byoung-HyunPARK, So RaKWON, Soon Keun
    • A61N7/00
    • A61N7/00
    • The present invention relates to an ultrasound equipment for treating edema, and more particularly, to an ultrasound equipment to relieve symptoms of edema or repair cellular and tissue edemas by generating 20-400 mW/cm of low intensity ultrasound and use thereof. The ultrasound equipment according to the present invention comprises a main control unit equipped with a control unit for ultrasound generation for generating a 20~400mW/cm2 of low intensity ultrasound, an ultrasound generator for generating ultrasound according to the operating state of the main control unit, an ultrasound vibrator vibrating according to the value of ultrasound data inputted from the ultrasound generator, and a probe for delivering ultrasound energy to a treatment site, and when the ultrasound equipment is used, it is possible to treat edema by increasing permeability in blood vessels.
    • 本发明涉及一种用于治疗水肿的超声设备,更具体地,涉及一种通过产生20-400mW / cm的低强度超声波及其应用来减轻水肿症状或修复细胞和组织水肿的超声设备。 根据本发明的超声波设备包括主控制单元,其配备有用于产生20〜400mW / cm 2的低强度超声波的超声波发生用控制单元,根据主控制单元的动作状态生成超声波的超声波发生器 ,根据从超声波发生器输入的超声波数据的振动振动的超声波振动器,以及用于将超声波能量输送到治疗部位的探针,当使用超声波设备时,可以通过增加血管的渗透性来治疗水肿 。
    • 6. 发明申请
    • METHOD FOR DIFFERENCIATING MESENCHYMAL STEM CELL AND CULTURING CHONDROCYTES USING ALGINATE COATED FIBRIN/HA COMPOSITE SCAFFOLD
    • 使用ALGINATE涂层FIBRIN / HA复合材料SCAFF的差异化MESENCHYMAL STEM CELL和培养CHONDROCYTES的方法
    • WO2009017267A1
    • 2009-02-05
    • PCT/KR2007/003710
    • 2007-08-01
    • REGENPRIME CO., LTD.MIN, Byoung-HyunPARK, So RaPARK, Sang-Hyug
    • MIN, Byoung-HyunPARK, So RaPARK, Sang-Hyug
    • C12N5/06C12N5/08C12N5/02C12N5/00
    • C12N5/0655C12N2533/56C12N2533/80
    • The present invention relates to a method for differentiating mesenchymal stem cells and culturing chondrocytes using a fibrin/HA(hyaluronate) composite whose biocompatibility and durability are enhanced, and a therapeutic composition containing the fibrin/HA composite, and more particularly, to a method for culturing chondrocytes and differentiating mesenchymal stem cells into chondrocytes using an alginate-coated fibrin/HA composite gel and a composition for treating a cartilage disease and a composition for treating a disc disease using a fibrin/HA composite scaffold containing a fibrin degradation inhibitor. According to the present invention, disadvantages of the traditional fibrin/HA composite being reduced in size and easily degraded in a short time period during culture were overcome, so that cells can be cultured in a more stable environment. The treatment composition according to the present invention has superior biocompatibility and biodegradability and thus it can be used for effective treatment for cartilage diseases, and it can regenerate the nuclei pulposi of a new intervertebral disk unlike currently used surgical treatment of degenerative intervertebral disk disease, so that it is expected that fundamental treatment of disc diseases can be achieved.
    • 本发明涉及使用生物相容性和耐久性增强的纤维蛋白/ HA(透明质酸盐)复合物和包含纤维蛋白/ HA复合物的治疗组合物来分化间充质干细胞和培养软骨细胞的方法,更具体地说,涉及一种用于 培养软骨细胞并使用藻酸盐包被的纤维蛋白/ HA复合凝胶和用于治疗软骨疾病的组合物和使用含有纤维蛋白降解抑制剂的纤维蛋白/ HA复合支架治疗椎间盘疾病的组合物将间充质干细胞分化成软骨细胞。 根据本发明,克服了传统纤维蛋白/ HA复合物在培养过程中尺寸减小并且在短时间内容易降解的缺点,使得细胞可以在更稳定的环境中培养。 根据本发明的治疗组合物具有优异的生物相容性和生物降解性,因此可用于软骨疾病的有效治疗,并且可以再生新型椎间盘的髓核,与目前使用的退行性椎间盘疾病的手术治疗不同,因此 预期可以实现椎间盘疾病的根本治疗。
    • 7. 发明申请
    • METHOD FOR PREPARING A CELL-DERIVED EXTRACELLULAR MATRIX MEMBRANE
    • 制备细胞衍生的细胞外基质膜的方法
    • WO2008035843A1
    • 2008-03-27
    • PCT/KR2007/002033
    • 2007-04-25
    • Filmiagen Co., LtdPARK, So RaMIN, Byoung-HyunCHOI, Byung Hyune
    • PARK, So RaMIN, Byoung-HyunCHOI, Byung Hyune
    • C12N5/08A61L27/60
    • A61L27/3633A61L27/3683A61L27/3817A61L27/60C12N5/0655C12N2533/90
    • The present invention relates to a method for preparing a cell-derived extracellular matrix membrane, more particularly, to a method for preparing a chondrocyte-derived ECM membrane, the method comprising the steps of forming a suitable thickness of ECM membrane by culturing chondrocytes derived from animal cartilage at a high concentration in vitro , and drying it after decellularization process. The cell-derived ECM membrane scaffold according to the present invention is composed of extracellular matrix secreted by chondrocytes so that the membrane has excellent biocompatibility as well as an immune-previlage effect specific to cartilage. Since the membrane also has a suitable compressive strength, it can be used to replace periosteum for cartilage regeneration or artificial collagen membrane and used as dura mater transplant material, a natural ECM membrane for treating skin loss, materials for cell transplantation and a growth factor delivery vehicle.
    • 本发明涉及一种制备细胞衍生的细胞外基质膜的方法,更具体地说涉及一种制备软骨细胞衍生的ECM膜的方法,所述方法包括以下步骤:通过培养衍生自软骨细胞的ECM软骨细胞形成适当厚度的ECM膜 体外高浓度的动物软骨,脱细胞后进行干燥。 根据本发明的细胞衍生的ECM膜支架由软骨细胞分泌的细胞外基质组成,使得膜具有优异的生物相容性以及对软骨特异性的免疫预先作用。 由于膜也具有合适的抗压强度,可用于替代软骨再生或人造胶原膜的骨膜,并用作硬膜移植材料,用于治疗皮肤损失的天然ECM膜,用于细胞移植的材料和生长因子递送 车辆。
    • 8. 发明申请
    • THERAPEUTIC COMPOSITE FOR CARTILAGE DISORDER USING EXTRACELLULAR MATRIX (ECM) SCAFFOLD
    • 使用细胞基质(ECM)SCAFFOLD的治疗疾病的治疗复合物
    • WO2008146956A1
    • 2008-12-04
    • PCT/KR2007/002215
    • 2007-05-06
    • MIN, Byoung-HyunPARK, So RaJIN, Cheng ZheCHOI, Byung Hyune
    • MIN, Byoung-HyunPARK, So RaJIN, Cheng ZheCHOI, Byung Hyune
    • A61L27/56
    • A61L27/56A61L27/3633A61L27/3817A61L27/3834A61L27/3852A61L2430/06
    • The present invention relates to a method for preparing a cell-derived ECM scaffold to which chondrocytes or stem cells are attached, a method for cartilage regeneration by tissue engineering, which comprises using the cell-derived ECM scaffold, and a therapeutic composition for treating cartilage disorder, which contains the ECM scaffold as an effective component. More specifically, the present invention relates to a method for cartilage regeneration by tissue engineering, which comprises transplanting ECM scaffold, having chondrocytes or stem cells attached thereto, into cartilage defects, and a therapeutic composition for treating cartilage disorder, which contains the ECM scaffold, having chondrocytes or stem cells attached thereto, as an effective component. According to the present invention, when the inventive ECM scaffold having chondrocytes or stem cells attached thereto is transplanted into a cartilage defect, mature articular cartilage having the same appearance and characteristics as those of natural cartilage tissue, can be regenerated without side effects such as inflammatory responses.
    • 本发明涉及一种制备软骨细胞或干细胞连接的细胞衍生的ECM支架的方法,一种通过组织工程软骨再生的方法,其包括使用细胞衍生的ECM支架和用于治疗软骨的治疗组合物 其包含ECM支架作为有效成分。 更具体地说,本发明涉及通过组织工程软骨再生的方法,其包括将附着有软骨细胞或干细胞的ECM支架移植到软骨缺损中,以及用于治疗软骨病症的治疗组合物,其含有ECM支架, 具有附着于其上的软骨细胞或干细胞作为有效成分。 根据本发明,当将附着有软骨细胞或干细胞的本发明的ECM支架移植到软骨缺损中时,具有与天然软骨组织相同的外观和特征的成熟关节软骨可以再生而无副作用,例如炎性 响应。